Search Results - S. A. Altynbekov
- Showing 1 - 4 results of 4
-
1
-
2
-
3
Comparative bioequivalence study of Pioglitazone tablets, 20 mg (JSC «Chimpharm», Kazakhstan) and Actos® Tablets, 30 mg («Eli Lilly Holdings, Takeda Global Research and Development... by A. K. Sariev, D. A. Abaimov, M. V. Shiryaev, E. Y. Styrova, S. A. Altynbekov, G. A. Dzholdygulov, V. N. Seryakov, Y. M. Budach, O. E. Kurilo
Published 2013-09-01
Article -
4